{
    "clinical_study": {
        "@rank": "4753", 
        "acronym": "CLL0911", 
        "arm_group": {
            "arm_group_label": "Study therapy", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Assessment of safety and efficacy of with fludarabine and cyclophosphamide (FC) combined\n      with ofatumumab (FCO2) in previously untreated \"young\" patients with Chronic Lymphocytic\n      Leukemia (CLL)."
        }, 
        "brief_title": "Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.", 
        "completion_date": {
            "#text": "November 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "B-cell Lymphoid Leukemia", 
            "Young Patients"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Lymphocytic, Chronic, B-Cell", 
                "Leukemia, Lymphoid"
            ]
        }, 
        "detailed_description": {
            "textblock": "Given that:\n\n        -  rituximab, fludarabine and cyclophosphamide (FCR) front-line treatment was associated\n           with a high OR rate, superior PFS and OS as compared to fludarabine and\n           cyclophosphamide regimen;\n\n        -  a direct relationship between the dose of rituximab and the response rate has been\n           reported;\n\n        -  ofatumumab, as single agent, proved activity in CLL patients with refractory disease;\n\n        -  ofatumumab, fludarabine and cylophosphamide (O-FC) front-line treatment has been\n           associated with a high complete response (CR) rate;\n\n        -  the expected grade 3-4 granulocytopenia could led to reduce the dose intensity of study\n           drugs (FC) and increase the infection rate; a schedule combining FC with an increased\n           dose of ofatumumab associated to primary phrophylaxis of granulocytopenia could be\n           associated with an improvement in the CR rate. The purpose of this study is to\n           determine whether we could improve the CR rate of the golden standard treatment for fit\n           patients with CLL , the FCR regimen, with a chemoimmunotherapy including FC combined\n           with an increased dose of the monoclonal antibody ofatumumab, given every other week\n           (FCO2) associated with a primary prophylaxis of granulocytopenia."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  B-cell CLL diagnosis by 2008 revised IWCLL criteria.\n\n          -  Treatment requirement according to the 2008 revised IWCLL criteria.\n\n          -  No previous treatment.\n\n          -  Age > 18 year and . 65 years.\n\n          -  ECOG performance status of 0-1 at study entry and CIRS score .6.\n\n          -  Adequate renal function (creatinine clearance.60 ml/min estimated using the\n             Cockcroft-Gaultequation) .\n\n          -  For male and female subjects of childbearing potential, agreement to use effective\n             contraception.\n\n          -  Signed written informed const according to ICH/EU/GCP and national local laws.\n\n        Exclusion Criteria:\n\n          -  Significant concurrent, uncontrolled medical condition including, but not limited to,\n             renal, hepatic, gastrointestinal, endocrine, pulmonary, neurological, cerebral or\n             psychiatric disease and/or laboratory abnormality which in the opinion of the\n             investigator may represent a risk for the patient and/or that would prevent the\n             subject from signing the informed consent form.\n\n          -  Pregnant or lactating females.\n\n          -  Known positive serology for HIV.\n\n          -  Positive serology for Hepatitis B (HBV) defined as a positive test for HBsAg and\n             HBV-DNA.\n\n          -  HCV-RNA positive.\n\n          -  Chronic or current infectious disease requiring systemic antibiotics, antifungal, or\n             antiviral treatment such as, but not limited to, chronic renal infection, chronic\n             chest infection, tuberculosis and active hepatitis.\n\n          -  History of tuberculosis within the last five years or recent exposure to tuberculosis\n             equal to or less than 6 months.\n\n          -  Known presence of alcohol and/or drug abuse.\n\n          -  Clinically significant cardiac disease including unstable angina, acute myocardial\n             infarction within six months prior to the inclusion in the study, congestive heart\n             failure (NYHA III-IV), arrhythmia unless controlled by therapy.. grade 2 neuropathy;\n             history of significant cerebrovascular disease in the past 6 months or ongoing event\n             with active symptoms or sequelae.\n\n          -  Uncontrolled autoimmune hemolytic anemia or thrombocytopenia.\n\n          -  One or more laboratory abnormalities:\n\n               1. Calculated creatinine clearance (Cockroft-Gault)<60mL/min.\n\n               2. Absolute granulocyte count <1500/\u0192\u00caL not disease related.\n\n               3. Platelet count < 75000/\u0192\u00caL not disease related.\n\n               4. GOT, GPT, GT, alkaline phosphatase > 1,5 x upper limit of normal value unless\n                  due to disease involvement); serum bilirubin >1.5mg/dL, subjects who have\n                  current active hepatic or biliary disease (with exception of patients with\n                  Gilbert's syndrome, asymptomatic gallstones)\n\n          -  Treatment with any known non-marketed drug substance or experimental therapy within 5\n             terminal half lives or 4 weeks prior to enrollment, whichever is longer, or currently\n             participating in any other interventional clinical study\n\n          -  Other past or current malignancy. Subjects who have been free of malignancy for at\n             least 5 years, or have a history of completely resected non-melanoma skin cancer, or\n             successfully treated in situ carcinoma are eligible."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01762202", 
            "org_study_id": "CLL0911", 
            "secondary_id": "2011-005329-27"
        }, 
        "intervention": [
            {
                "arm_group_label": "Study therapy", 
                "intervention_name": "Cyclophosphamide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Study therapy", 
                "intervention_name": "Fludarabine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Study therapy", 
                "intervention_name": "Ofatumumab", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclophosphamide", 
                "Fludarabine monophosphate", 
                "Fludarabine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "CLL", 
            "Fludarabine", 
            "Cyclophosphamide", 
            "Ofatumumab"
        ], 
        "lastchanged_date": "January 30, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Silvia Baraldi"
                }, 
                "facility": {
                    "address": {
                        "city": "Alessandria", 
                        "country": "Italy"
                    }, 
                    "name": "S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo"
                }, 
                "investigator": [
                    {
                        "last_name": "Anna Baraldi", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Flavia Salvi", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Piero Galieni"
                }, 
                "facility": {
                    "address": {
                        "city": "Ascoli", 
                        "country": "Italy"
                    }, 
                    "name": "Dipartimento Area Medica - Presidio Ospedaliero \"C. e G.Mazzoni\""
                }, 
                "investigator": [
                    {
                        "last_name": "Piero Galieni", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Emanuela Troiani", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giorgina Specchia"
                }, 
                "facility": {
                    "address": {
                        "city": "Bari", 
                        "country": "Italy"
                    }, 
                    "name": "UO Ematologia con trapianto-Universit\u00e0 degli Studi di Bari Aldo Moro"
                }, 
                "investigator": [
                    {
                        "last_name": "Giorgina Specchia", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Anna Maria Giordano", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sergio Storti"
                }, 
                "facility": {
                    "address": {
                        "city": "Campobasso", 
                        "country": "Italy"
                    }, 
                    "name": "U.O.C. di Onco-Ematologia - Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche"
                }, 
                "investigator": [
                    {
                        "last_name": "Sergio Storti", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Vincenzo Fraticelli", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Stefano Molica"
                }, 
                "facility": {
                    "address": {
                        "city": "Catanzaro", 
                        "country": "Italy"
                    }, 
                    "name": "Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unit\u00e0 Operativa di Ematologia"
                }, 
                "investigator": [
                    {
                        "last_name": "Stefano Molica", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Rosanna Mirabelli", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Antonio Cuneo"
                }, 
                "facility": {
                    "address": {
                        "city": "Ferrara", 
                        "country": "Italy"
                    }, 
                    "name": "Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna"
                }, 
                "investigator": [
                    {
                        "last_name": "Antonio Cuneo", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Gian Matteo Rigolin", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Alberto Bosi, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy"
                    }, 
                    "name": "Policlinico Careggi"
                }, 
                "investigator": [
                    {
                        "last_name": "Alberto Bosi, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Stefania Ciolli, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Angelo Michele Carella"
                }, 
                "facility": {
                    "address": {
                        "city": "Genova", 
                        "country": "Italy"
                    }, 
                    "name": "RCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11\u00b0piano- lato ponente"
                }, 
                "investigator": [
                    {
                        "last_name": "Angelo Michele Carella", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Mauro Spriano", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nicola Di Renzo"
                }, 
                "facility": {
                    "address": {
                        "city": "Lecce", 
                        "country": "Italy"
                    }, 
                    "name": "ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE"
                }, 
                "investigator": [
                    {
                        "last_name": "Nicola Di Renzo", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "M.R. De Paolis", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maura Brugiatelli, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Messina", 
                        "country": "Italy"
                    }, 
                    "name": "Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti \"Papardo Piemonte\""
                }, 
                "investigator": [
                    {
                        "last_name": "Maura Brugiatelli, Pr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Laura Nocilli, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Caterina Musolino"
                }, 
                "facility": {
                    "address": {
                        "city": "Messina", 
                        "country": "Italy"
                    }, 
                    "name": "Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina"
                }, 
                "investigator": [
                    {
                        "last_name": "Caterina Musolino", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Alessandro Allegra", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Alessandria Tedeschi, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy"
                    }, 
                    "name": "Ospedale Niguarda \" Ca Granda\""
                }, 
                "investigator": [
                    {
                        "last_name": "Alessandria Tedeschi, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Marco Montillo, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Agostino Cortelezzi, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy"
                    }, 
                    "name": "UO Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico"
                }, 
                "investigator": [
                    {
                        "last_name": "Agostino Cortelezzi, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Gianluca Reda, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gianluca Gaidano"
                }, 
                "facility": {
                    "address": {
                        "city": "Novara", 
                        "country": "Italy"
                    }, 
                    "name": "S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Universit\u00e0 del Piemonte Orientale Amedeo Avogadro"
                }, 
                "investigator": [
                    {
                        "last_name": "Gianluca Gaidano", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Davide Rossi", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sergio Siragusa"
                }, 
                "facility": {
                    "address": {
                        "city": "Palermo", 
                        "country": "Italy"
                    }, 
                    "name": "Divisione di Ematologia con trapianto di midollo - A.U. Policlinico \"Paolo Giaccone\""
                }, 
                "investigator": [
                    {
                        "last_name": "Sergio Siragusa", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Simona Raso", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Francesco Nobile, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Reggio Calabria", 
                        "country": "Italy"
                    }, 
                    "name": "Dipartimento Emato-Oncologia A.O.\"Bianchi-Melacrino-Morelli\""
                }, 
                "investigator": [
                    {
                        "last_name": "Francesco Nobile, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Donatella Vincelli, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Anna Lia, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Rimini", 
                        "country": "Italy"
                    }, 
                    "name": "Ospedale \"Infermi\""
                }, 
                "investigator": [
                    {
                        "last_name": "Anna Lia, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Anna Merli, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Luca Laurenti, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 Cattolica del Sacro Cuore - Policlinico A. Gemelli"
                }, 
                "investigator": [
                    {
                        "last_name": "Luca Laurenti, Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Barbara Vannata, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Roberto Fo\u00e0"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "Policlinico Umberto I, Hematology Department - Sapienza"
                }, 
                "investigator": [
                    {
                        "last_name": "Roberto Fo\u00e0, Pr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Francesca R. Mauro, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giovanni Del Poeta"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "U.O.C. Ematologia - Ospedale S.Eugenio"
                }, 
                "investigator": [
                    {
                        "last_name": "Giovanni Del Poeta", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Dario Raguso", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sergio Amadori"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 degli Studi - Policlinico di Tor Vergata"
                }, 
                "investigator": [
                    {
                        "last_name": "Sergio Amadori", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ilaria Del Principe", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Monica Bocchia"
                }, 
                "facility": {
                    "address": {
                        "city": "Siena", 
                        "country": "Italy"
                    }, 
                    "name": "U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico \" Le Scotte\""
                }, 
                "investigator": {
                    "last_name": "Monica Bocchia", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Anna Marina Liberati"
                }, 
                "facility": {
                    "address": {
                        "city": "Terni", 
                        "country": "Italy"
                    }, 
                    "name": "SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni"
                }, 
                "investigator": [
                    {
                        "last_name": "Anna Marina Liberati", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ilaria Angeletti", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Massimo Massaia"
                }, 
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy"
                    }, 
                    "name": "Div. di Ematologia Ospedale \"S.Giovanni Battista\""
                }, 
                "investigator": [
                    {
                        "last_name": "Massimo Massaia", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Marta Coscia", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Lorella Orsucci"
                }, 
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy"
                    }, 
                    "name": "SCDO Ematologia 2 AOU S.Giovanni Battista"
                }, 
                "investigator": [
                    {
                        "last_name": "Lorella Orsucci", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Patrizia Pregno", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Francesco Zaja"
                }, 
                "facility": {
                    "address": {
                        "city": "Udine", 
                        "country": "Italy"
                    }, 
                    "name": "Clinica Ematologica - Policlinico Universitario"
                }, 
                "investigator": [
                    {
                        "last_name": "Francesco Zaja", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Maddalena Mazzucco", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Achille Ambrosetti"
                }, 
                "facility": {
                    "address": {
                        "city": "Verona", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi"
                }, 
                "investigator": [
                    {
                        "last_name": "Achille Ambrosetti", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Roberta Zanotti", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase 2 Multicenter, Study to Assess the Efficacy and the Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab (FCO2) Chemoimmunotherapy in Young (\u226465 Yrs) Patients With Chronic Lymphocytic Leukemia (CLL).", 
        "overall_contact": {
            "email": "p.fazi@gimema.it", 
            "last_name": "Paola Fazi, Dr."
        }, 
        "overall_contact_backup": {
            "email": "e.crea@gimema.it", 
            "last_name": "Enrico Crea"
        }, 
        "overall_official": [
            {
                "affiliation": "Policlinico Umberto I, Hematology Department.", 
                "last_name": "Roberto Fo\u00e0, Pr.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Policlinico Umberto I, Hematology Department.", 
                "last_name": "Francesca R. Mauro", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The complete response (CR) rate after FCO2 front-line treatment.", 
            "measure": "Number of complete responses.", 
            "safety_issue": "No", 
            "time_frame": "After 8 months from study entry."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01762202"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Overall Response (OR) rate after FCO2 front-line treatment.", 
                "measure": "Number of overall responses.", 
                "safety_issue": "No", 
                "time_frame": "After 8 months from study entry."
            }, 
            {
                "description": "Progression-free survival (PFS) calculated from the date of first treatment dose - induction phase - until the date of the first documentation of progressive disease or until death (whatever the cause), whichever occurs first. Patients still alive and known to be progression free will be censored at the moment of last follow-up.", 
                "measure": "Number of patients in progression-free survival.", 
                "safety_issue": "No", 
                "time_frame": "After 32 months from study entry."
            }, 
            {
                "description": "Time to a new CLL treatment (TTT) will be calculated from the date of last treatment dose until date of a new treatment received for CLL, where death occurred before the new treatment will be considered as competing risk. Patients still alive without receiving a new treatment will be censored at the time of the last follow-up.", 
                "measure": "Number of patients needing a new CLL Treatment.", 
                "safety_issue": "No", 
                "time_frame": "After 32 months from study entry."
            }, 
            {
                "description": "Overall survival (OS): defined as the time interval between the date of first treatment dose - induction phase- and the date of death for any cause; patients still alive will be censored at the moment of last follow-up.", 
                "measure": "Number of patients in overall survival", 
                "safety_issue": "No", 
                "time_frame": "After 32 months from study entry."
            }, 
            {
                "description": "Toxicity of treatment according the last NCI criteria.", 
                "measure": "Number of toxic events.", 
                "safety_issue": "Yes", 
                "time_frame": "After 32 months from study entry."
            }, 
            {
                "description": "Outcome of patients (response, PFS OS) according to clinical and biologic variables (age; size of nodes, 2-microglobulin, lymphocyte count, stage, IgVH, p53, FISH, ZAP-70, CD38, FLCs).", 
                "measure": "Outcome of patients according to clinical and biologica variables.", 
                "safety_issue": "No", 
                "time_frame": "After 32 months from study entry."
            }
        ], 
        "source": "Gruppo Italiano Malattie EMatologiche dell'Adulto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gruppo Italiano Malattie EMatologiche dell'Adulto", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}